BLX-301 is a humanized monoclonal antibody against CD20, exhibiting antitumor activity. It is applicable in studies related to diseases such as non-Hodgkins lymphoma and rheumatoid arthritis.
CAS Number:
[2170268-76-3]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted
